Notice to postpone annual general meeting IGEA Pharma N.V.

Dear Shareholder,

On 27 May 2022, the board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) invited you to (virtually) attend the annual general meeting on 30 June 2022 (the “AGM”), at offices of the Company at Siriusdreef 17, 2123 WT Hoofddorp, the Netherlands.

Read More

Note of the Board

The Board notices that the drafts of the Annual Report and the Annual Accounts for the financial year 2021 will unfortunately not be available in time for the upcoming AGM and therefore these documents as such cannot be approved and adopted, as the case may be, by the general meeting.

Read More

Convening notice and agenda

Dear Shareholder,

The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites you to (virtually) attend the annual general meeting on 30 June 2022 (the “AGM”), at offices of the Company at Siriusdreef 17, 2123 WT Hoofddorp, the Netherlands. The meeting will start at 10:00 hours CEST. Registration will start at 9:30 hours CEST.

Read More

IGEA pharma non-executive board members resigned after completion of the first post-combination phase. New members to be nominated

Hoofddorp, the Netherlands, 1February 2022. Today the Board of Directors of IGEA Pharma N.V. (SIX: IGPH) has acknowledged the resignation of Mrs Giovanna Puppo, Mr Raffaele Bertoni, Mr Lieven Baten and Mr Massimiliano Colella as members of the Board of Directors. The resignation is effective as of 31 January 2022 and is motivated by personal reasons.

Read More